Pfizer Archives

Todos Medical – The Lotto Play with 10 to 1 Payout Challenges Pfizer’s Drug

The Covid stocks have gotten murdered and most are on life support or dead with the exception of Pfizer (NYSE: PFE). Todos...

211

Biotech

The Next Axcella (AXLA) Squeeze –> Bioxytran (BIXT)

Axcella Therapeutics (NASDAQ: AXLA) mesmerized investors yesterday with news of a patent to treat fatigue in Long COVID. The short squeeze setup...

732

Biotech

$BIXT Spikes on Delayed Reaction to the Most Powerful Drug Since Penicillin

Bioxytran Inc. (OTCMKTS: BIXT) is perhaps one of the most undervalued biotechs in OTC. There is a real chance that if this...

1.0K

1

Biotech

New CDC Guidelines Revive COVID Therapeutic Need for VERU TOMDF CYDY

If you thought COVID-19 was over, think again because the latest relaxation of pandemic measures by the CDC was dropped yesterday. The...

699

1

Biotech

Monkeypox Stocks Heating Up the Charts: TOMDF APDN CODX

Investors are facing the sober reality of a twin pandemic, COVID-19, and monkeypox. It’s now clear that the government missed the opportunity...

1.9K

Biotech

Todos (OTCMKTS: TOMDF) CEO Nails NewsMax Interview With Critical Messages About the Pandemic

This Saturday Todos Medical’s (OTCMKTS: TOMDF) CEO set the stage for future international media exposure. This interview was powerful, gripping, and informative...

1.0K

Biotech

Why Todos Medical (OTCMKTS: TOMDF) is Running Ahead of the Pack

Todos Medical (OTCMKTS: TOMDF) was a value play before it started running recently based on sound fundamental analysis, and now investors are...

966

1

Biotech

Picking a Bottom in CytoDyn – Right Now

CytoDyn Inc (OTCMKT: CYDY) has been under considerable selling pressure since April and nothing seems to be able to stop it. In...

3.0K

Biotech

Atea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals

The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...